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Summary and general discussion
Important physiological functions of the liver include the metabolism and disposal of (po-
tentially) toxic endo- and xenobiotics. These compounds are secreted by the liver for
removal via bile or urine. This secretion involves speciﬁc transport proteins that, in most
cases, belong to the ATP-binding cassette (ABC) transporter superfamily. ABC trans-
porters have the capacity to actively transport compounds out of the cell against steep
concentration gradients. In this way, liver cells lower the intracellular concentrations of
potentially toxic compounds. High expression levels of speciﬁc ABC transporters can thus
protect the cell from damage.
The liver has the capacity to regenerate after loss of tissue. A commonly used model
to study liver regeneration in experimental animals is the surgical removal of ∼70% of the
liver (partial hepatectomy, PHx). Under these circumstances, the remaining liver cells will
start to replicate but at the same time must maintain their normal metabolic functions as
good as possible. In chapter 2 the expression of hepatic transport systems involved in
bile formation during liver regeneration after PHx in rats has been studied. Initial studies
showed maximal DNA synthesis at 24 hours after PHx. Therefore, transporter expression
and bile formation were analyzed in detail at this timepoint. Serum bile salt levels were
highly increased after PHx, as a result of the reduced hepatic transport capacity. The
expression of hepatic uptake transporters was markedly decreased, limiting the uptake of
bile salts into the hepatocyte. The expression of proteins involved in bile salt secretion was,
however, maintained at a normal level. As bile ﬂow and bile salt secretion were increased
when expressed per gram liver, the remnant liver was not cholestatic. Hepatocytes in the
remnant liver showed highly increased levels of Mdr1b mRNA, which may increase the
resistance of hepatocytes against products of cellular oxidative stress reactions, such as
lipid peroxidation. In addition, a number of cytochrome P450 proteins are known to be
down-regulated after PHx, possibly to reduce formation of reactive oxygen species and
risk of DNA damage during cell division. Up-regulation of Mdr1b by the cell could be a
compensatory pathway to enable transport of substrates, not metabolized via cytochrome
P450, directly into the bile.
Liver damage results in activation of hepatic progenitor cells when proliferation of
hepatocytes is suppressed. These progenitor cells are located in the canals of Hering, which
form the connection between the hepatocytic canaliculi and the bile ductules. Activation of
these progenitor cells results in the generation of bipotential oval cells, able to diﬀerentiate
into hepatocytes or into cholangiocytes. As these oval cells provide a mechanism for the
liver to regenerate after severe injury, they must be well protected against toxic damage.
High expression levels of speciﬁc ABC transporters would be beneﬁcial in this respect.
However, ABC transporter gene expression had thus far not been characterized in oval cells.
In rats, oval cell proliferation can be achieved by treatment with 2-acetylaminoﬂuorene (2-
AAF), which inhibits proliferation of hepatocytes, after which regeneration is induced by
PHx. Chapter 3 describes the expression proﬁle of ABC transporters in 2-AAF/PHx-
treated rats. In total liver the mRNA levels of Mdr1b were highly increased. In addition,
mRNA levels of Mrp1 and Mrp3 were increased. Using immunohistochemistry, we could
localize the increased Mdr1b expression to the periportal hepatocytes whereas oval cells
expressed Mrp1 and Mrp3.
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Figure 1: Schematic representation of relative ABC transporter gene expression in hepatocytes, cholan-
giocytes and Thy-1 positive cells
The oval cells were further characterized by comparing isolated Thy-1 positive cells
with isolated cholangiocytes and hepatocytes. It has been shown that Thy-1 expression
in the liver is speciﬁc for oval cells. This allows the speciﬁc isolation of these cells by
ﬂow cytometry. Thy-1 positive cells highly expressed Mrp1 and Mrp3 mRNA, while the
hepatocyte-speciﬁc transporters Mdr2, Bsep, Mrp2, and Mrp6 were minimally expressed.
The expression pattern of ABC transporters in Thy-1 positive cells resembled that of
cholangiocytes except for Abca1, which was expressed in Thy-1 positive cells but not in
cholangiocytes. Thy-1 positive cells showed a surprisingly low expression of Mdr1b mRNA,
comparable to resting hepatocytes and cholangiocytes. These results are summarized in
Figure 1. The rat liver epithelial cell line RLE ϕ13, often used as a model for hepatic
oval cells, was found to retain the ABC expression proﬁle of oval cells by and large, but
did have a high mRNA expression level of Mdr1b. Data are interpreted to indicate that
hepatocytes are protected by high levels of Mdr1b, while oval cells are protected by high
levels of Mrp1 and Mrp3. Via Mrp1, the latter cells are able to eﬃciently remove products
of oxidative stress reactions such as GSSG or the GSH conjugate of 4-hydroxynonenal. High
expression of Mrp3, on the other hand, allows for the export of bile salts and glucuronidated
compounds.
Hepatic progenitor cells are also activated in various human liver diseases, for instance
during viral infections. In chapter 4, we studied the expression of ABC transporters
in human liver specimens from patient diagnosed with primary biliary cirrhosis, chronic
hepatitis C, or submassive liver cell necrosis and compared these with normal liver. By
using dilution series of speciﬁc antibodies, we were able to quantify the degree of up- or
down-regulation of protein expression. In normal liver, hepatocytes and cholangiocytes
expressed MDR1. MRP3 was expressed in cholangiocytes and in hepatocytes surrounding
the central vein. MRP2 and BSEP expression was, as expected, hepatocyte-speciﬁc. There
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was no detectable expression of MRP1. Under conditions of regeneration after massive
hepatocyte loss, remaining hepatocytes expressed high levels of MDR1, MRP1, and MRP3.
Expression of MRP2 and BSEP was only decreased in hepatocytes with severe cholate
stasis. At the same time, expression of MDR1, MRP1, and MRP3 was highly increased in
ductular structures close to the parenchyma. It has been postulated that these ductules
form a reservoir in which toxic bile can accumulate. MRP3 may function as a basolateral
transporter, extruding bile salts back into the systemic circulation.
A striking diﬀerence in ABC transporter gene expression between the rat model de-
scribed in chapter 3 and the human liver specimens studied in chapter 4 relates to the
expression pattern of Mdr1b versus MDR1. Whereas progenitor cells in rats do not show
high expression levels of any of the P-glycoproteins, MDR1 is highly expressed in human
progenitor cells. This may be related to the severity of liver damage, as the human liver
specimens were obtained from patients with end-stage liver disease. In addition, MDR1
levels in humans are in general higher than the Mdr1a/Mdr1b counterparts in laboratory
animals.
The most pronounced eﬀect of PHx in rats was on the expression of Mdr1b (chapter
2). In chapter 5, we aimed to gain insight in the regulatory mechanism involved in
this induction. As the cytokine tumor necrosis factor-alpha (TNF-α) has an essential role
in liver regeneration after PHx, we hypothesized that Mdr1b expression after PHx was,
at least in part, induced by TNF-α. We developed an in vitro system, using cultured
primary rat hepatocytes or a rat hepatoma cell line, in which Mdr1b mRNA levels could
be induced by TNF-α. We selectively used constructs expressing dominant negative Fas-
associated death domain protein (FADD), TNF receptor associated factor-2 (TRAF2) or
IκB to inhibit pathways downstream of TNF receptor-1. Inhibition of NF-κB activation
prevented induction of Mdr1b gene expression by TNF-α, demonstrating the essential role
of NF-κB in the induction of Mdr1b by TNF-α. Because p53 is up-regulated by TNF-α
in an NF-κB-dependent manner and the Mdr1b promoter contains a p53 binding site, we
used liver cells expressing a dominant negative p53 to show that TNF-α up-regulation of
Mdr1b is independent of functional p53. Using transient transfection assays we were able
to show that Mdr1b up-regulation correlated with activation of the promoter. Mutation of
the NF-κB site in the Mdr1b promoter prevented its induction by TNF-α, showing that
activation of the rat Mdr1b gene by TNF-α is a direct result of NF-κB binding to the
promoter.
From these studies we conclude that there is increased expression of speciﬁc ABC trans-
porters in diﬀerent hepatic cell types during liver regeneration. Proliferating hepatocytes
express high levels of Mdr1b. Likewise, hepatocytes in severely damaged livers express
Mdr1b/MDR1. Rat hepatic oval cells express high levels of Mrp1 and Mrp3, whereas
human progenitor cells express high levels of MDR1, MRP1, and MRP3. We hypothe-
size that expression of these transporters help these cells to withstand the unfavourable
conditions associated with severe liver damage. Understanding the protective function of
these transporters, together with elucidation of the regulatory mechanisms involved, may
contribute to the development of novel therapies for severe liver diseases.
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